Literature DB >> 21874614

Acute kidney injury in a girl with ulcerative colitis and cytomegalovirus-induced focal segmental glomerular sclerosis.

Sankar R Chirumamilla1, Chun He, Lorraine C Racusen, Ann O Scheimann, Carmen Cuffari.   

Abstract

BACKGROUND: Mesalamine or 5-aminosalicylic acid (5-ASA) has proven efficacy in treating patients with ulcerative colitis (UC). Although mesalamine is considered safe, it has been associated with acute interstitial nephritis and renal failure.
METHODS: Herein we present a case of a child with UC who developed acute renal failure on mesalamine therapy.
RESULTS: A 15-year-old African-American girl with well-controlled UC presented to the Johns Hopkins Hospital with a four-day history of high fever, malaise, generalized body aches, and productive non-bloody cough. Over the next three days, she developed acute renal failure with fluid retention, and elevated serum creatinine and blood urea nitrogen. A kidney biopsy showed drug induced acute interstitial nephritis and focal segmental glomerulosclerosis with viral inclusion bodies likely secondary to cytomegalovirus.
CONCLUSION: When treating UC patients with a history of underlying renal disease, it is advised to carefully monitor renal function while on mesalamine therapy.

Entities:  

Mesh:

Year:  2011        PMID: 21874614     DOI: 10.1007/s12519-011-0302-8

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  8 in total

1.  Acute renal failure in a 53-year-old woman with Crohn's disease treated with 5-aminosalicylic acid.

Authors:  M Haas; K R Shetye
Journal:  Am J Kidney Dis       Date:  2001-07       Impact factor: 8.860

2.  Experience of 5-aminosalicylate nephrotoxicity in the United Kingdom.

Authors:  A F Muller; P E Stevens; A S McIntyre; H Ellison; R F Logan
Journal:  Aliment Pharmacol Ther       Date:  2005-05-15       Impact factor: 8.171

Review 3.  Primary chronic interstitial nephritis in Crohn's disease.

Authors:  Hassane Izzedine; Jeanne Simon; Anne-Marie Piette; Michel Lucsko; Alain Baumelou; Didier Charitanski; Eve Kernaonet; Anne-Catherine Baglin; Gilbert Deray; Hélène Beaufils
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

4.  Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss.

Authors:  E A Masson; J M Rhodes
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

5.  Chronic interstitial nephritis due to 5-aminosalicylic acid.

Authors:  M Agharazii; J Marcotte; D Boucher; R Noël; M Lebel
Journal:  Am J Nephrol       Date:  1999       Impact factor: 3.754

6.  Acute tubular injury associated with mesalazine therapy in an adolescent girl with inflammatory bowel disease.

Authors:  Nuray Uslu; Hulya Demir; Inci Nur Saltik-Temizel; Rezan Topaloğlu; Figen Gürakan; Aysel Yüce
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

7.  Recurrent acute interstitial nephritis induced by azithromycin.

Authors:  Neha Soni; John W Harrington; Robert Weiss; Praveen Chander; Shefali Vyas
Journal:  Pediatr Infect Dis J       Date:  2004-10       Impact factor: 2.129

Review 8.  The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented.

Authors:  George L Bakris; Eberhard Ritz
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-03       Impact factor: 3.738

  8 in total
  1 in total

Review 1.  5-ASA induced interstitial nephritis in patients with inflammatory bowel disease: a systematic review.

Authors:  James G Moss; Christopher M Parry; Richard C L Holt; Stephen J McWilliam
Journal:  Eur J Med Res       Date:  2022-04-29       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.